Heart attack survivors get a secret weapon: a mini monitor that spots hidden danger

NCT ID NCT05073419

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

After a heart attack, patients face a high risk of dangerous heart rhythms, but current monitoring methods may miss them. This trial tests whether a small implantable cardiac monitor (ICM) placed under the skin can catch these rhythms earlier and help doctors adjust treatment. Two hundred adults who recently had a heart attack will either receive the ICM or standard follow-up care. The goal is to see if the device leads to more timely and effective treatment changes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Implantable cardiac monitor (ICM)
What this could lead to
If successful, this could show that routine monitoring with an ICM helps doctors detect and treat heart rhythm problems earlier after a heart attack, potentially improving survival.
What could go wrong
This is a small, early-phase study (200 participants) focused on detecting arrhythmias, not on proving survival benefit. The monitor may find harmless rhythms that lead to unnecessary procedures, or it may not change outcomes at all.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UPMC Presbyterian Hospital

    RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.